PaxMedica appoints Hough as Chief Medical Officer

PaxMedica announced the return of David Hough, M.D., as Chief Medical Officer, CMO, of PaxMedica, effective immediately. Dr. Hough has been a key consultant to the company during 2023 and was the company’s CMO from 2020-2022. He is board-certified in both adult and geriatric psychiatry. He succeeds Stefan Schwabe M.D., PhD, who will continue to serve on the PaxMedica Scientific Advisory Board. PaxMedica also announced additional changes to the management team and Board of Directors, all effective as of August 21, 2023. Michael Derby and Zachary Rome, Chairman of the Board and Chief Operating Officer, respectively, and co-founders of the company in 2018, will be relinquishing their operational roles on the management team in order to focus on their full-time responsibilities at Tardimed Sciences. Rome will remain on the Board of Directors. Derby will remain as a consultant to PaxMedica.